Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,975 JPY | -0.57% |
|
+1.61% | -20.33% |
04-12 | Cosmos Pharmaceutical's Attributable Profit Up 6.6% in Fiscal Nine Months | MT |
01-12 | Cosmos Pharmaceutical’s Attributable Profit Up 2.6% in Fiscal H1 on Expansion of Stores | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.33% | 3.2B | |
-10.55% | 2.95B | |
-29.13% | 2.77B | |
+2.47% | 2.49B | |
-20.15% | 1.92B | |
-5.21% | 1.79B | |
-29.47% | 854M | |
-51.84% | 545M | |
-0.53% | 423M | |
+10.78% | 408M |
- Stock Market
- Equities
- 3349 Stock
- News COSMOS Pharmaceutical Corporation
- UBS Adjusts Cosmos Pharmaceutical's Price Target to 16,500 Yen From 17,500 Yen, Keeps at Neutral